Financial statements Vitae Biotech
Balance sheet of Vitae Biotech
Company age:
Age:
6 y. 6 m. 28 d.
Share capital:
Share capital:
5 000 PLN
Company suspended its operations from 2025-06-23
Balance sheet data of VITAE BIOTECH
|
Year
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|
| Total assets | 10 724,89 | 6 507,82 | 6 629,63 | 6 580,98 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 10 724,89 | 6 507,82 | 6 629,63 | 6 580,98 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | - |
| D. Own shares (stocks) | - | 0,00 | 0,00 | - |
| Total liabilities | 10 724,89 | 6 507,82 | 6 629,63 | 6 580,98 |
| A. Equity | -5 911,79 | -12 737,63 | -18 901,26 | -25 795,91 |
| B. Liabilities and provisions for liabilities | 16 636,68 | 19 245,45 | 25 530,89 | 32 376,89 |
| I. Long-term liabilities | 0,00 | - | - | - |
| II. Short-term liabilities | 16 636,68 | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.